[Remicade (infliximab) in the treatment of Crohn disease].
Brazier
F
F
Service d'Hépato-Gastroentérologie, CHU, Amiens.
Delcenserie
R
R
Dupas
J L
JL
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000075202:Contraindications; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D004311:Double-Blind Method; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D010919:Placebos; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D010919:Placebos; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab